High-Dose Platinum versus Standard Dose in Advanced Ovarian Carcinoma: A Randomized Trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)

Author： Joly F.   Heron J.F.   Kerbrat P.   Chauvergne J.   Rios M.   Mayer F.   Chinet-Charrot P.   Goupil A.   Lebrun-Jezekova D.   Vennin D.   Lhomme C.   Mace-Lesec'h J.   Crouet H.   for the Gynecologic Cooperative Group FNCLCC  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.78, Iss.3, 2000-09, pp. : 361-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

By Schilder R.J.   Brady M.F.   Spriggs D.   Shea T.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 3-8

Academic Press

Access to resources Recommend Favorite

Phase II Trial of 5-Fluorouracil and High-Dose Leucovorin in Recurrent Adenocarcinoma of the Cervix: A Gynecologic Oncology Group Study

By Look K.Y.   Blessing J.A.   Valea F.A.   McGehee R.   Manetta A.   Webster K.D.   Andersen W.A.  

Gynecologic Oncology, Vol. 67, Iss. 3, 1997-12 ,pp. : 255-258

Elsevier

Access to resources Recommend Favorite

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer - a randomised phase II-III trial of the EORTC Gastrointestinal Group

By Wils J.   Blijham G.H.   Wagener T.   De Greve J.   Jansen R.L.H.   Kok T.C.   Nortier J.W.R.   Bleiberg H.   Couvreur M.L.   Genicot B.   Baron B.   on behalf of the EORTC Gastrointestinal Group  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 346-352

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: First results of a randomized trial

By Verrill Mark  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 41-43

Informa Healthcare

Access to resources Recommend Favorite

Phase 2 Trial of Moderately High Dose Single Agent Mitoxantrone in Platinum and Paclitaxel-Refractory Ovarian Cancer

By Markman M.   Lichtman S.M.   Homesley H.   Kennedy A.   Webster K.   Ernst S.   Omura G.   Belinson J.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite